These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 26619367)

  • 1. Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.
    Tan L; Wang W; He G; Kuick RD; Gossner G; Kueck AS; Wahl H; Opipari AW; Liu JR
    Cancer; 2016 Mar; 122(5):722-9. PubMed ID: 26619367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol inhibits glucose metabolism in human ovarian cancer cells.
    Kueck A; Opipari AW; Griffith KA; Tan L; Choi M; Huang J; Wahl H; Liu JR
    Gynecol Oncol; 2007 Dec; 107(3):450-7. PubMed ID: 17825886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway.
    Liu Y; Tong L; Luo Y; Li X; Chen G; Wang Y
    J Cell Biochem; 2018 Jul; 119(7):6162-6172. PubMed ID: 29663499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
    Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.
    Saed GM; Fletcher NM; Diamond MP; Morris RT; Gomez-Lopez N; Memaj I
    Gynecol Oncol; 2018 Mar; 148(3):567-575. PubMed ID: 29329880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Picropodophyllin inhibits epithelial ovarian cancer cells in vitro and in vivo.
    Lu X; Wang L; Mei J; Wang X; Zhu X; Zhang Q; Lv J
    Biochem Biophys Res Commun; 2013 Jun; 435(3):385-90. PubMed ID: 23665331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling.
    Chang CH; Lee CY; Lu CC; Tsai FJ; Hsu YM; Tsao JW; Juan YN; Chiu HY; Yang JS; Wang CC
    Int J Oncol; 2017 Mar; 50(3):873-882. PubMed ID: 28197628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
    Chen J; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of glucose regulated protein 78 on autophagy and apoptosis in ovarian epithelial carcinoma].
    Li M; Tian J; Qu Q
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):848-53. PubMed ID: 26887774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
    Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P
    Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target.
    Lee MH; Choi BY; Kundu JK; Shin YK; Na HK; Surh YJ
    Cancer Res; 2009 Sep; 69(18):7449-58. PubMed ID: 19738051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP30 protein from Momordica charantia is therapeutic and has synergic activity with cisplatin against ovarian cancer in vivo by altering metabolism and inducing ferroptosis.
    Chan DW; Yung MM; Chan YS; Xuan Y; Yang H; Xu D; Zhan JB; Chan KK; Ng TB; Ngan HY
    Pharmacol Res; 2020 Nov; 161():105157. PubMed ID: 32814169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells.
    Gao Y; Shan N; Zhao C; Wang Y; Xu F; Li J; Yu X; Gao L; Yi Z
    Int J Clin Exp Pathol; 2015; 8(5):4923-32. PubMed ID: 26191185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways.
    Zhang M; Zhou X; Zhou K
    Int J Mol Med; 2013 Mar; 31(3):621-7. PubMed ID: 23314035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol-induced autophagocytosis in ovarian cancer cells.
    Opipari AW; Tan L; Boitano AE; Sorenson DR; Aurora A; Liu JR
    Cancer Res; 2004 Jan; 64(2):696-703. PubMed ID: 14744787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells.
    Pastò A; Pagotto A; Pilotto G; De Paoli A; De Salvo GL; Baldoni A; Nicoletto MO; Ricci F; Damia G; Bellio C; Indraccolo S; Amadori A
    Oncotarget; 2017 Jan; 8(4):6433-6445. PubMed ID: 28031535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.
    Chiu WT; Huang YF; Tsai HY; Chen CC; Chang CH; Huang SC; Hsu KF; Chou CY
    Oncotarget; 2015 Feb; 6(4):2349-65. PubMed ID: 25537512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of autophagy by ARHI (DIRAS3) alters fundamental metabolic pathways in ovarian cancer models.
    Ornelas A; McCullough CR; Lu Z; Zacharias NM; Kelderhouse LE; Gray J; Yang H; Engel BJ; Wang Y; Mao W; Sutton MN; Bhattacharya PK; Bast RC; Millward SW
    BMC Cancer; 2016 Oct; 16(1):824. PubMed ID: 27784287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer.
    Bradley A; Zheng H; Ziebarth A; Sakati W; Branham-O'Connor M; Blumer JB; Liu Y; Kistner-Griffin E; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Landen CN; Eblen ST
    Carcinogenesis; 2014 May; 35(5):1100-9. PubMed ID: 24379240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
    Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
    Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.